Exploratory Study Evaluating the Effects of Darifenacin on Nocturia, Sleep and Daytime Wakefulness
Status:
Withdrawn
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy of darifenacin in the treatment of
moderate to severe nocturia in patients with overactive bladder and who do not have
non-urologic causes of nocturia.